Distribution of global respiratory therapy market by condition 2018-2019

This statistic displays the global respiratory therapy market by condition based on the MAT (moving annual total) until the third quarter of 2019 (October 2018 to September 2019). In that year, the global asthma therapy market generated 20.9 billion U.S. dollars. Asthma is a major cause of morbidity and mortality globally and it is thought to have become more prevalent in the last decades. Fixed combination doses of preventative and symptomatic treatments are used to combat moderate to severe asthma.

Distribution of global respiratory therapy market by condition in 2018-2019 (in billion U.S. dollars)*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

March 2020

Region

Worldwide

Survey time period

Q4 2018 to Q3 2019

Supplementary notes

* MAT (moving annual total) 3rd quarter 2019.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical brands: Advair/Seretide (GlaxoSmithKline)"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.